Janux Therapeutics Inc

NASDAQ:JANX   3:59:55 PM EDT
10.41
-0.32 (-2.98%)
Earnings Announcements

Janux Therapeutics Posts Qtrly Loss Per Share $0.33

Published: 03/18/2022 20:15 GMT
Janux Therapeutics Inc (JANX) - Janux Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results.
Janux Therapeutics Inc - $375.0 Million in Year-end 2021 Cash, Cash Equivalents and Short-term Investments.
Janux Therapeutics Inc - Qtrly Loss per Share $0.33.
Revenue is expected to be $0.85 Million
Adjusted EPS is expected to be -$0.34

Next Quarter Revenue Guidance is expected to be $0.82 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.